These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 34959992)
1. Curcumin in Metabolic Health and Disease. Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959992 [TBL] [Abstract][Full Text] [Related]
2. Potential Health Benefits of Curcumin on Female Reproductive Disorders: A Review. Kamal DAM; Salamt N; Yusuf ANM; Kashim MIAM; Mokhtar MH Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579002 [TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes. Zabihi NA; Pirro M; Johnston TP; Sahebkar A Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192 [TBL] [Abstract][Full Text] [Related]
4. Antidiabetic Properties of Curcumin I: Evidence from In Vitro Studies. Den Hartogh DJ; Gabriel A; Tsiani E Nutrients; 2020 Jan; 12(1):. PubMed ID: 31906278 [TBL] [Abstract][Full Text] [Related]
5. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Shehzad A; Ha T; Subhan F; Lee YS Eur J Nutr; 2011 Apr; 50(3):151-61. PubMed ID: 21442412 [TBL] [Abstract][Full Text] [Related]
6. Turmeric and Curcumin: From Traditional to Modern Medicine. Akaberi M; Sahebkar A; Emami SA Adv Exp Med Biol; 2021; 1291():15-39. PubMed ID: 34331682 [TBL] [Abstract][Full Text] [Related]
7. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials. Goodarzi R; Sabzian K; Shishehbor F; Mansoori A Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773 [TBL] [Abstract][Full Text] [Related]
8. Curcumin: Could This Compound Be Useful in Pregnancy and Pregnancy-Related Complications? Filardi T; Varì R; Ferretti E; Zicari A; Morano S; Santangelo C Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080891 [TBL] [Abstract][Full Text] [Related]
9. The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial. Heshmati J; Golab F; Morvaridzadeh M; Potter E; Akbari-Fakhrabadi M; Farsi F; Tanbakooei S; Shidfar F Diabetes Metab Syndr; 2020; 14(2):77-82. PubMed ID: 31991296 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893 [TBL] [Abstract][Full Text] [Related]
14. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Banez MJ; Geluz MI; Chandra A; Hamdan T; Biswas OS; Bryan NS; Von Schwarz ER Nutr Res; 2020 Jun; 78():11-26. PubMed ID: 32428778 [TBL] [Abstract][Full Text] [Related]
15. Curcumin and Health. Pulido-Moran M; Moreno-Fernandez J; Ramirez-Tortosa C; Ramirez-Tortosa M Molecules; 2016 Feb; 21(3):264. PubMed ID: 26927041 [TBL] [Abstract][Full Text] [Related]
16. Supplementation with curcumin inhibits intestinal cholesterol absorption and prevents atherosclerosis in high-fat diet-fed apolipoprotein E knockout mice. Zou J; Zhang S; Li P; Zheng X; Feng D Nutr Res; 2018 Aug; 56():32-40. PubMed ID: 30055772 [TBL] [Abstract][Full Text] [Related]
17. Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin. Kuszewski JC; Wong RHX; Howe PRC Adv Nutr; 2018 Mar; 9(2):105-113. PubMed ID: 29659685 [TBL] [Abstract][Full Text] [Related]
18. Curcumin, Cardiometabolic Health and Dementia. Kim Y; Clifton P Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30250013 [TBL] [Abstract][Full Text] [Related]
19. The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Mirhafez SR; Farimani AR; Gholami A; Hooshmand E; Tavallaie S; Nobakht M Gh BF Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145689 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]